Iveda (Nasdaq: IVDA) has set the terms for a public offering consisting of 5,714,286 shares of common stock or pre-funded warrants, along with series X warrants to purchase up to 11,428,572 shares. The combined price for each share or pre-funded warrant and accompanying series X warrant is $0.35. The series X warrants are exercisable immediately and will expire two years after issuance.
The company expects to complete the offering around February 11, 2026, pending customary closing conditions.
**Why this matters**
This offering provides Iveda with additional capital that may support its operations and growth initiatives. The issuance of warrants offers investors potential future equity participation, which could impact the company’s capital structure.
Source: NewsData